Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update U.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1H’25 Strengthened leadership...

ViraCor-IBT Laboratories to Present at the American College of Allergy, Asthma and Immunology's Annual Meeting LENEXA, KS and LEE'S SUMMIT, MO--(Marketwire - November 4, 2009) - Scientists from ViraCor-IBT Laboratories have been selected to provide four oral presentations and one poster presentation at this...